1. Home
  2. MOBX vs PDSB Comparison

MOBX vs PDSB Comparison

Compare MOBX & PDSB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Mobix Labs Inc.

MOBX

Mobix Labs Inc.

HOLD

Current Price

$2.94

Market Cap

25.4M

Sector

N/A

ML Signal

HOLD

Logo PDS Biotechnology Corporation

PDSB

PDS Biotechnology Corporation

HOLD

Current Price

$0.92

Market Cap

29.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
MOBX
PDSB
Founded
2020
2005
Country
United States
United States
Employees
46
10
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
25.4M
29.6M
IPO Year
N/A
2015

Fundamental Metrics

Financial Performance
Metric
MOBX
PDSB
Price
$2.94
$0.92
Analyst Decision
Strong Buy
Analyst Count
0
2
Target Price
N/A
$9.00
AVG Volume (30 Days)
5.1M
1.1M
Earning Date
05-14-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
28.16
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.13
$0.51
52 Week High
$3.87
$1.90

Technical Indicators

Market Signals
Indicator
MOBX
PDSB
Relative Strength Index (RSI) 65.34 46.94
Support Level $0.46 $0.62
Resistance Level $3.87 $1.12
Average True Range (ATR) 0.42 0.18
MACD 0.02 -0.02
Stochastic Oscillator 42.42 27.76

Price Performance

Historical Comparison
MOBX
PDSB

About MOBX Mobix Labs Inc.

Mobix Labs Inc designs, develops and sells components and systems for wireless and wired connectivity, radio frequency (RF), switching and electromagnetic interference (EMI) filtering technologies. Its wireless systems solutions include products for RF and millimeter wave (mmWave) communications, mmWave imaging, software defined radio and custom RF integrated circuits (ICs) targeting the defense, aerospace, commercial and industrial sectors. The majority of the company's revenue is derived from product sales to equipment manufacturers. Geographically, it generates the maximum revenue from the United States.

About PDSB PDS Biotechnology Corporation

PDS Biotechnology Corp operates as a clinical stage biotechnology company, principally involved in drug discovery in the United States. It is engaged in the treatment of various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its products are based on the proprietary Versamune platform technology, which activates and directs the human immune system to unleash a powerful and targeted attack against cancer cells.

Share on Social Networks: